跳至主要内容
临床试验/NCT01153139
NCT01153139已完成2 期

Long-term Bilateral Theta Burst Stimulation for the Treatment of Major Depression

University Hospital Tuebingen1 个研究点 分布在 1 个国家目标入组 32 人开始时间: 2010年4月最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
32
试验地点
1
主要终点
Number of responders (response = decrease of the Montgomery-Åsberg Depression Rating Scale for at least 50%)

研究概览

简要总结

Repetitive transcranial magnetic stimulation has been shown to be moderately effective in the treatment of major depression. Theta burst stimulation (TBS) is a new form of rTMS that may exert larger effects.

This sham-controlled study examines the effectivity of daily bilateral TBS to the dorsolateral frontal cortex over 6 weeks in 2x16 patients with major depression add on to the local standard of a combined pharmacological/psychotherapeutical treatment.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • major Depression
  • informed consent

排除标准

  • seizures in medical history
  • metallic implants
  • deep brain stimulation
  • cardiac pacemaker
  • brain trauma
  • psychotic symptoms
  • substance abuse
  • pregnancy
  • Benzodiazepines other than Lorazepam >1mg/d

结局指标

主要结局

Number of responders (response = decrease of the Montgomery-Åsberg Depression Rating Scale for at least 50%)

时间窗: after the end of treatment (week 6)

次要结局

  • Change of the Hamilton rating scale for depression (HAMD 17)(baseline, after the end of treatment (week 6))
  • Change of the Beck Depression Inventory (BDI)(baseline, after the end of treatment (week 6))
  • Change of the Montgomery-Asberg rating scale for depression (MADRS) score(baseline, after the end of treatment (week 6))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Christian Plewnia, MD

Prof. Dr. med.

University Hospital Tuebingen

研究点 (1)

Loading locations...

相似试验